• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Halloran Consulting Group adds Joanna Engelke as managing director

Halloran Consulting Group adds Joanna Engelke as managing director

January 12, 2017
CenterWatch Staff

Halloran Consulting Group, a national consultancy to life science companies of all sizes, has announced that Joanna Engelke joined the company as managing director and will work to guide Halloran clients around complex regulatory and quality challenges.

Engelke joins Halloran from Boston Scientific with deep expertise in medical device quality and regulatory matters, as well as valuable consulting expertise, from her years as a partner at Bain & Company.

“Joanna is instrumental in shifting industry perception to view quality as an intrinsic value in life science companies,” said Halloran Consulting Group CEO Laurie Halloran. “Joanna is a true leader in quality and compliance and has set the standard. Her work has focused on building quality into the culture of life science organizations. Halloran’s partners will benefit greatly from her experience, and we welcome her.”

She will work to grow Halloran’s expertise in helping life science companies of all sizes transform and restore their business and increase the visibility of services available to larger companies in this sector. Engelke was a key player in turning Boston Scientific into an industry leader in quality assurance. She is skilled in navigating intricate quality situations to resolution based on quality data that drives improvements, innovation, and impacts the bottom line.

“My time at Boston Scientific enabled me to lead efforts that made substantial change in how quality was regarded and protected in a leading medical device company. I am looking forward to the opportunity to make real and lasting changes to improve more life science companies,” said Engelke.

In addition to her leadership roles at Boston Scientific and Bain & Company, Engelke also served as Portfolio CEO at Puretech Ventures and VP and GM of specialty products at Dade Behring. Her dedication to the life science industry is evident in her recent prominent role on an FDA-sponsored initiative to build quality assurance into the medical device field. She received her MBA from Harvard Business School and her Bachelor’s degree in political science from Yale University.

"Our clients, present and future, will find great value in Joanna's experience and guidance," said Greg Dombal, COO at Halloran. “Joanna is not afraid to roll up her sleeves and delve into the work of helping companies see quality as a tool to drive transformation and growth.”

Upcoming Events

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • MachineLearning-360x240.png

    Industry Using AI/ML to Improve Data, Quality and Trial Management, Survey Says

  • VirtualTraining-360x240.png

    Virtual Training Evolves into More In-Depth Learning, Improved Communications

  • SurveywBlueBackground-360x240.png

    Mid-Study Updates Delay Trials At Least a Month, CSDD Report Finds

  • Real-TimeData-360x240.png

    Real-Time Data Helped Sponsors Respond to Sites’ Needs During the Pandemic

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing